Impact of a national external quality assessment scheme for breast pathology in the UK

被引:63
作者
Ellis, IO
Coleman, D
Wells, C
Kodikara, S
Paish, EM
Moss, S
Al-Sam, S
Anderson, N
Bobrow, L
Buley, I
Connolly, CE
Dallimore, NS
Hales, S
Hanby, A
Humphreys, S
Knox, F
Lowe, J
Macartney, J
Nash, R
Parham, D
Patnick, J
Pinder, SE
Quinn, CM
Robertson, AJ
Shrimankar, J
Walker, RA
Winder, R
机构
[1] City Hosp Nottingham, Dept Histopathol, Nottingham NG5 1PB, England
[2] Inst Canc Res, Canc Screening Evaluat Unit, Sutton SM2 5NG, Surrey, England
[3] St Bartholomews Med Sch, Dept Histopathol, London EC1A 9DS, England
[4] Broomfield Hosp, Dept Histopathol, Chelmsford CM1 7ET, Essex, England
[5] Royal Grp Hosp Trust, Dept Pathol, Belfast BT12 6BA, Antrim, North Ireland
[6] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England
[7] John Radcliffe Hosp, Dept Histopathol, Oxford OX3 9DU, England
[8] Univ Coll Hosp Galway, Dept Pathol, Galway, Ireland
[9] Llandough Hosp, Dept Histopathol, Penarth CF64 2XX, S Glam, Wales
[10] Countess Chester Hosp, Dept Pathol, Chester CH2 1UL, Cheshire, England
[11] St James Univ Hosp, Dept Histopathol, Leeds LS9 7TF, W Yorkshire, England
[12] Med Solut, London W1G 9QP, England
[13] Wythenshawe Hosp, Dept Histopathol, Manchester M23 9LT, Lancs, England
[14] Univ Hosp N Tees, Dept Histopathol, Stockton On Tees TS19 8PE, England
[15] Univ Hosp Coventry & Warwickshire, Dept Histopathol, Coventry CV1 4FH, W Midlands, England
[16] Univ London St Georges Hosp, Dept Cellular Pathol, London SW17 0QT, England
[17] Royal Bournemouth Hosp, Dept Pathol, Bournemouth BH7 7DW, Dorset, England
[18] NHS Canc Screening Programme, Sheffield ST10 3TH, S Yorkshire, England
[19] St Vincents Univ Hosp, Dept Histopathol, Dublin 4, Ireland
[20] Univ Dundee, Dept Pathol, Dundee DD1 9SY, Scotland
[21] Univ Leicester, Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester LE1 5WW, Leics, England
[22] NHS Breast Screening Programme, Sheffield ST10 3TH, S Yorkshire, England
[23] NHS Cerv Screening Programme, Sheffield ST10 3TH, S Yorkshire, England
关键词
D O I
10.1136/jcp.2004.025551
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: This article presents the results and observed effects of the UK National Health Service Breast Screening Programme (NHSBSP) external quality assurance scheme in breast histopathology. Aims/Methods: The major objectives were to monitor and improve the consistency of diagnoses made by pathologists and the quality of prognostic information in pathology reports. The scheme is based on a twice yearly circulation of 12 cases to over 600 registered participants. The level of agreement was generally measured using k statistics. Results: Four main situations were encountered with respect to diagnostic consistency, namely: ( 1) where consistency is naturally very high-this included diagnosing in situ and invasive carcinomas ( and certain distinctive subtypes) and uncomplicated benign lesions; ( 2) where the level of consistency was low but could be improved by making guidelines more detailed and explicit-this included histological grading; ( 3) where consistency could be improved but only by changing the system of classification-this included classification of ductal carcinoma in situ; and ( 4) where no improvement in consistency could be achieved-this included diagnosing atypical hyperplasia and reporting vascular invasion. Size measurements were more consistent for invasive than in situ carcinomas. Even in cases where there is a high level of agreement on tumour size, a few widely outlying measurements were encountered, for which no explanation is readily forthcoming. Conclusions: These results broadly confirm the robustness of the systems of breast disease diagnosis and classification adopted by the NHSBSP, and also identify areas where improvement or new approaches are required.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 18 条
[1]   Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years [J].
Anderson, TJ ;
Sufi, F ;
Ellis, IO ;
Sloane, JP ;
Moss, S .
HUMAN PATHOLOGY, 2002, 33 (03) :365-371
[2]   Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications:: A comparative study with long follow-up [J].
Badve, S ;
A'Hern, RP ;
Ward, AM ;
Millis, RR ;
Pinder, SE ;
Ellis, IO ;
Gusterson, BA ;
Sloane, JP .
HUMAN PATHOLOGY, 1998, 29 (09) :915-923
[3]   STATISTICAL-METHODS FOR ASSESSING OBSERVER VARIABILITY IN CLINICAL MEASURES [J].
BRENNAN, P ;
SILMAN, A .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6840) :1491-1494
[4]   Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast [J].
Elston, CW ;
Sloane, JP ;
Amendoeira, I ;
Apostolikas, N ;
Bellocq, JP ;
Bianchi, S ;
Boecker, W ;
Bussolati, G ;
Coleman, D ;
Connolly, CE ;
Dervan, P ;
Drijkoningen, M ;
Eusebi, V ;
Faverly, D ;
Holland, R ;
Jacquemier, J ;
Lacerda, M ;
Martinez-Penuela, J ;
de Miguel, C ;
Moss, S ;
Munt, C ;
Peterse, JL ;
Rank, F ;
Reiner, A ;
Sylvan, M ;
Wells, CA ;
Zafrani, B .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (14) :1769-1772
[5]   MEASUREMENT OF OBSERVER AGREEMENT FOR CATEGORICAL DATA [J].
LANDIS, JR ;
KOCH, GG .
BIOMETRICS, 1977, 33 (01) :159-174
[6]   Standard for breast conservation therapy in the management of invasive breast carcinoma [J].
Morrow, M ;
Strom, EA ;
Bassett, LW ;
Dershaw, DD ;
Fowble, B ;
Giuliano, A ;
Harris, JR ;
O'Malley, F ;
Schnitt, SJ ;
Singletary, SE ;
Winchester, DP .
CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (05) :277-300
[7]  
*NAT COORD GROUP B, 1989, PATH REP BREAST SCRE
[8]  
*NAT COORD GROUP B, 1995, NHS BSP PUBL, V3
[9]   COMBINED HISTOLOGIC AND CYTOLOGIC CRITERIA FOR THE DIAGNOSIS OF MAMMARY ATYPICAL DUCTAL HYPERPLASIA [J].
PAGE, DL ;
ROGERS, LW .
HUMAN PATHOLOGY, 1992, 23 (10) :1095-1097
[10]   INTEROBSERVER AND INTRAOBSERVER VARIABILITY IN THE HISTOPATHOLOGICAL DIAGNOSIS OF MEDULLARY CARCINOMA OF THE BREAST, AND ITS PROGNOSTIC IMPLICATIONS [J].
PEDERSEN, L ;
HOLCK, S ;
SCHIODT, T ;
ZEDELER, K ;
MOURIDSEN, HT .
BREAST CANCER RESEARCH AND TREATMENT, 1989, 14 (01) :91-99